The DOI matches its Crossref record; 136 of the 136 references it cites were found in a registry or an index.
Cyclic peptide drugs approved in the last two decades (2001–2021)
Open accessAbstract
In this mini-review, we summarized the chemical structure, mechanism of action, and metabolism of cyclic peptide drugs approved in the last two decades. We also examined factors important for the development and utilization in clinical situations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Walsh, T. J., Anaissie, E. J., Denning, D. W., Herbrecht, R., Kontoyiannis, D. P., Marr, K. A., Morrison, V. A., Segal, B. H., Steinbach, W. J., Stevens, D. A., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/525258 · Cited by 2,706
Trends in GPCR drug discovery: new agents, targets and indications
Hauser, A. S., Attwood, M. M., Rask-Andersen, M., Schiöth, H. B., & Gloriam, D. E. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.178 · Cited by 2,627
Denning, D. W. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14472-8 · Cited by 1,131
Contemporary strategies for peptide macrocyclization
White, C. J., & Yudin, A. K. (2011) · Nature Chemistry · doi:10.1038/nchem.1062 · Cited by 1,088
Cell‐penetrating peptides: 20 years later, where do we stand?
Bechara, C., & Sagan, S. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.04.031 · Cited by 857
Macrocyclic Peptides as Drug Candidates: Recent Progress and Remaining Challenges
Vinogradov, A. A., Yin, Y., & Suga, H. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.8b13178 · Cited by 848
Getting Across the Cell Membrane: An Overview for Small Molecules, Peptides, and Proteins
Yang, N. J., & Hinner, M. J. (2015) · Methods in Molecular Biology · doi:10.1007/978-1-4939-2272-7_3 · Cited by 826
Phage-encoded combinatorial chemical libraries based on bicyclic peptides
Heinis, C., Rutherford, T., Freund, S., & Winter, G. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.184 · Cited by 743
Cyclic peptide therapeutics: past, present and future
Zorzi, A., Deyle, K., & Heinis, C. (2017) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2017.02.006 · Cited by 737
Meyler's Side Effects of Drugs
Breckenridge, A. M. (1976) · BMJ · doi:10.1136/bmj.2.6030.307 · Cited by 691
Studies on the Physiological Functions of the Melanocortin System
Cone, R. D. (2006) · Endocrine Reviews · doi:10.1210/er.2006-0034 · Cited by 615
Understanding Cell Penetration of Cyclic Peptides
Dougherty, P. G., Sahni, A., & Pei, D. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.9b00008 · Cited by 570
Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections
Steenbergen, J. N., Alder, J., Thorne, G. M., & Tally, F. P. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh546 · Cited by 561
UEDA, H., NAKAJIMA, H., HORI, Y., FUJITA, T., NISHIMURA, M., GOTO, T., & OKUHARA, M. (1994) · The Journal of Antibiotics · doi:10.7164/antibiotics.47.301 · Cited by 489
FR901228, a Potent Antitumor Antibiotic, Is a Novel Histone Deacetylase Inhibitor
Nakajima, H., Kim, Y. B., Terano, H., Yoshida, M., & Horinouchi, S. (1998) · Experimental Cell Research · doi:10.1006/excr.1998.4027 · Cited by 487
Proopiomelanocortin Deficiency Treated with a Melanocortin-4 Receptor Agonist
Kühnen, P., Clément, K., Wiegand, S., Blankenstein, O., Gottesdiener, K., Martini, L. L., Mai, K., Blume-Peytavi, U., Grüters, A., & Krude, H. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1512693 · Cited by 485
THPdb: Database of FDA-approved peptide and protein therapeutics
Usmani, S. S., Bedi, G., Samuel, J. S., Singh, S., Kalra, S., Kumar, P., Ahuja, A. A., Sharma, M., Gautam, A., & Raghava, G. P. S. (2017) · PLOS ONE · doi:10.1371/journal.pone.0181748 · Cited by 485
A neural basis for melanocortin-4 receptor–regulated appetite
Garfield, A. S., Li, C., Madara, J. C., Shah, B. P., Webber, E., Steger, J. S., Campbell, J. N., Gavrilova, O., Lee, C. E., Olson, D. P., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.4011 · Cited by 440
Internalization mechanisms of cell-penetrating peptides
Ruseska, I., & Zimmer, A. (2020) · Beilstein Journal of Nanotechnology · doi:10.3762/bjnano.11.10 · Cited by 436
Rezai, T., Bock, J. E., Zhou, M. V., Kalyanaraman, C., Lokey, R. S., & Jacobson, M. P. (2006) · Journal of the American Chemical Society · doi:10.1021/ja063076p · Cited by 416
Improving Oral Bioavailability of Peptides by Multiple N‐Methylation: Somatostatin Analogues
Biron, E., Chatterjee, J., Ovadia, O., Langenegger, D., Brueggen, J., Hoyer, D., Schmid, H. A., Jelinek, R., Gilon, C., Hoffman, A., et al. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200705797 · Cited by 374
Miao, V., Coëffet-LeGal, M.-F., Brian, P., Brost, R., Penn, J., Whiting, A., Martin, S., Ford, R., Parr, I., Bouchard, M., et al. (2005) · Microbiology · doi:10.1099/mic.0.27757-0 · Cited by 368
Neri, D., & Lerner, R. A. (2018) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-062917-012550 · Cited by 364
Dvorchik, B. H., Brazier, D., DeBruin, M. F., & Arbeit, R. D. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.4.1318-1323.2003 · Cited by 358
Kurtz, M. B., Heath, I. B., Marrinan, J., Dreikorn, S., Onishi, J., & Douglas, C. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.7.1480 · Cited by 320
Pogliano, J., Pogliano, N., & Silverman, J. A. (2012) · Journal of Bacteriology · doi:10.1128/jb.00011-12 · Cited by 319
Ziconotide: a review of its pharmacology and use in the treatment of pain
McGivern, J. G. (2007) · Neuropsychiatric Disease and Treatment · doi:10.2147/nedt.2007.3.1.69 · Cited by 310
MC4R agonism promotes durable weight loss in patients with leptin receptor deficiency
Clément, K., Biebermann, H., Farooqi, I. S., Van der Ploeg, L., Wolters, B., Poitou, C., Puder, L., Fiedorek, F., Gottesdiener, K., Kleinau, G., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0015-9 · Cited by 309
Kristensen, M., Birch, D., & Mørck Nielsen, H. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17020185 · Cited by 304
Evaluation of a melanocortin-4 receptor (MC4R) agonist (Setmelanotide) in MC4R deficiency
Collet, T.-H., Dubern, B., Mokrosinski, J., Connors, H., Keogh, J. M., Mendes de Oliveira, E., Henning, E., Poitou-Bernert, C., Oppert, J.-M., Tounian, P., et al. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.06.015 · Cited by 302
Echinocandins: a new class of antifungal
Denning, D. W. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf045 · Cited by 300
Seamless Proteins Tie Up Their Loose Ends
Craik, D. J. (2006) · Science · doi:10.1126/science.1125248 · Cited by 283
Mechanism of action of oritavancin and related glycopeptide antibiotics
Allen, N. (2003) · FEMS Microbiology Reviews · doi:10.1016/s0168-6445(02)00144-4 · Cited by 276
Patel, S. G., Sayers, E. J., He, L., Narayan, R., Williams, T. L., Mills, E. M., Allemann, R. K., Luk, L. Y. P., Jones, A. T., & Tsai, Y.-H. (2019) · Scientific Reports · doi:10.1038/s41598-019-42456-8 · Cited by 276
Vigneaud, V. D., Lawler, H. C., & Popenoe, E. A. (1953) · Journal of the American Chemical Society · doi:10.1021/ja01115a554 · Cited by 271
Antifungal Drugs: The Current Armamentarium and Development of New Agents
Robbins, N., Wright, G. D., & Cowen, L. E. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.funk-0002-2016 · Cited by 271
Houšť, J., Spížek, J., & Havlíček, V. (2020) · Metabolites · doi:10.3390/metabo10030106 · Cited by 254
Pharmacotherapy of obesity: available medications and drugs under investigation.
Pilitsi, E., Farr, O. M., Polyzos, S. A., Perakakis, N., Nolen-Doerr, E., Papathanasiou, A.-E., & Mantzoros, C. S. (2019) · Metabolism · doi:10.1016/j.metabol.2018.10.010 · Cited by 248
Ligation Technologies for the Synthesis of Cyclic Peptides
Chow, H. Y., Zhang, Y., Matheson, E., & Li, X. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00657 · Cited by 246
The synthesis of cyclic peptides
Lambert, J. N., Mitchell, J. P., & Roberts, K. D. (2001) · Journal of the Chemical Society, Perkin Transactions 1 · doi:10.1039/b001942i · Cited by 231
Seltzer, E., Dorr, M. B., Goldstein, B. P., Perry, M., Dowell, J. A., Henkel, T., & Dalbavancin Skin and Soft-Tissue Infection Study Group (2003) · Clinical Infectious Diseases · doi:10.1086/379015 · Cited by 231
Sohrabi, C., Foster, A., & Tavassoli, A. (2020) · Nature Reviews Chemistry · doi:10.1038/s41570-019-0159-2 · Cited by 227
Cell-Permeable Cyclic Peptides from Synthetic Libraries Inspired by Natural Products
Hewitt, W. M., Leung, S. S. F., Pye, C. R., Ponkey, A. R., Bednarek, M., Jacobson, M. P., & Lokey, R. S. (2015) · Journal of the American Chemical Society · doi:10.1021/ja508766b · Cited by 210
Bryant, A. P., Busby, R. W., Bartolini, W. P., Cordero, E. A., Hannig, G., Kessler, M. M., Pierce, C. M., Solinga, R. M., Tobin, J. V., Mahajan-Miklos, S., et al. (2010) · Life Sciences · doi:10.1016/j.lfs.2010.03.015 · Cited by 208
A RaPID way to discover nonstandard macrocyclic peptide modulators of drug targets
Passioura, T., & Suga, H. (2017) · Chemical Communications · doi:10.1039/c6cc06951g · Cited by 193
Half-life extended biotherapeutics
Kontermann, R. E. (2016) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2016.1165661 · Cited by 191
Form and Function in Cyclic Peptide Natural Products: A Pharmacokinetic Perspective
Bockus, A. T., McEwen, C. M., & Lokey, R. S. (2013) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026611313070005 · Cited by 187
Bicyclic Peptide Inhibitor Reveals Large Contact Interface with a Protease Target
Angelini, A., Cendron, L., Chen, S., Touati, J., Winter, G., Zanotti, G., & Heinis, C. (2012) · ACS Chemical Biology · doi:10.1021/cb200478t · Cited by 182
Self-citationBattle of GLP-1 delivery technologies
Yu, M., Benjamin, M. M., Srinivasan, S., Morin, E. E., Shishatskaya, E. I., Schwendeman, S. P., & Schwendeman, A. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.07.009 · Cited by 180
Oritavancin Kills Stationary-Phase and Biofilm Staphylococcus aureus Cells In Vitro
Belley, A., Neesham-Grenon, E., McKay, G., Arhin, F. F., Harris, R., Beveridge, T., Parr, T. R., & Moeck, G. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00766-08 · Cited by 178
Qian, Z., LaRochelle, J. R., Jiang, B., Lian, W., Hard, R. L., Selner, N. G., Luechapanichkul, R., Barrios, A. M., & Pei, D. (2014) · Biochemistry · doi:10.1021/bi5004102 · Cited by 176
Chen, K. Y., Muniyappa, R., Abel, B. S., Mullins, K. P., Staker, P., Brychta, R. J., Zhao, X., Ring, M., Psota, T. L., Cone, R. D., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-4024 · Cited by 174
THE PURIFICATION AND THE AMINO ACID CONTENT OF VASOPRESSIN PREPARATIONS
Turner, R. A., Pierce, J. G., & du Vigneaud, V. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)50947-9 · Cited by 171
Lunde, C. S., Hartouni, S. R., Janc, J. W., Mammen, M., Humphrey, P. P., & Benton, B. M. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01710-08 · Cited by 170
Origin, structure, and activity in vitro and in vivo of dalbavancin
Malabarba, A., & Goldstein, B. P. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki005 · Cited by 167
Oritavancin: Mechanism of Action
Zhanel, G. G., Schweizer, F., & Karlowsky, J. A. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cir920 · Cited by 167
Discovery and development of first in class antifungal caspofungin (CANCIDAS®)—A case study
Balkovec, J. M., Hughes, D. L., Masurekar, P. S., Sable, C. A., Schwartz, R. E., & Singh, S. B. (2013) · Natural Product Reports · doi:10.1039/c3np70070d · Cited by 160
Physiologic Studies of Antidiuretic Hormone by Its Direct Measurement in Human Plasma *
Czaczkes, J. W., Kleeman, C. R., Koenig, M., & Boston, R. (1964) · Journal of Clinical Investigation · doi:10.1172/jci105038 · Cited by 157
Conformational Control of Macrocycles by Remote Structural Modification
Appavoo, S. D., Huh, S., Diaz, D. B., & Yudin, A. K. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00742 · Cited by 157
Total Synthesis of the Antitumor Depsipeptide FR-901,228
Li, K. W., Wu, J. J., Xing, W., & Simon, J. A. (1996) · Journal of the American Chemical Society · doi:10.1021/ja9613724 · Cited by 154
Kofla, G., & Ruhnke, M. (2011) · European Journal of Medical Research · doi:10.1186/2047-783x-16-4-159 · Cited by 153
GLASS: a comprehensive database for experimentally validated GPCR-ligand associations
Chan, W. K. B., Zhang, H., Yang, J., Brender, J., Hur, J., Özgür, A., & Zhang, Y. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btv302 · Cited by 151
Self-citationConstruction of Natural-Product-Like Cyclophane-Braced Peptide Macrocycles via sp3 C–H Arylation
Li, B., Li, X., Han, B., Chen, Z., Zhang, X., He, G., & Chen, G. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.9b04221 · Cited by 151
Identification of highly selective covalent inhibitors by phage display
Chen, S., Lovell, S., Lee, S., Fellner, M., Mace, P. D., & Bogyo, M. S. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0733-7 · Cited by 147
Self-citationGlas, A., Bier, D., Hahne, G., Rademacher, C., Ottmann, C., & Grossmann, T. N. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201310082 · Cited by 145
A biomimetic approach for enhancing the in vivo half-life of peptides
Penchala, S., Miller, M. R., Pal, A., Dong, J., Madadi, N. R., Xie, J., Joo, H., Tsai, J. W., Batoon, P. H. M., Samoshin, V. V., et al. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1907 · Cited by 144
Zorzi, A., Middendorp, S. J., Wilbs, J., Deyle, K., & Heinis, C. (2017) · Nature Communications · doi:10.1038/ncomms16092 · Cited by 141
Vasopressin and its analogues in shock states: a review
Demiselle, J., Fage, N., Radermacher, P., & Asfar, P. (2020) · Annals of Intensive Care · doi:10.1186/s13613-020-0628-2 · Cited by 138
Peptide Ligands Stabilized by Small Molecules
Chen, S., Bertoldo, D., Angelini, A., Pojer, F., & Heinis, C. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201309459 · Cited by 137
Self-citationOritavancin Exhibits Dual Mode of Action to Inhibit Cell-Wall Biosynthesis in Staphylococcus aureus
Kim, S. J., Cegelski, L., Stueber, D., Singh, M., Dietrich, E., Tanaka, K. S. E., Parr, T. R., Far, A. R., & Schaefer, J. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.01.031 · Cited by 134
Pharmacodynamics of Telavancin (TD-6424), a Novel Bactericidal Agent, against Gram-Positive Bacteria
Hegde, S. S., Reyes, N., Wiens, T., Vanasse, N., Skinner, R., McCullough, J. L., Kaniga, K., Pace, J., Thomas, R., Shaw, J., et al. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.8.3043-3050.2004 · Cited by 134
Rand, A. C., Leung, S. S. F., Eng, H. F., Rotter, C. J., Sharma, R., Kalgutkar, A. S. S., Zhang, Y., Varma, M. V. S., Farley, K. A., Khunte, B., et al. (2012) · MedChemComm · doi:10.1039/c2md20203d · Cited by 132
Echinocandins and pneumocandins--a new antifungal class with a novel mode of action
Denning, D. W. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/40.5.611 · Cited by 126
Clinical review: Vasopressin and terlipressin in septic shock patients.
Delmas, A., Léone, M., Rousseau, S., Albanèse, J., & Martin, C. (2004) · Critical Care · doi:10.1186/cc2945 · Cited by 125
Dalbavancin: a novel antimicrobial
Chen, A. Y., Zervos, M., & Vazquez, J. A. (2007) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2007.01318.x · Cited by 123
Bremelanotide: An Overview of Preclinical CNS Effects on Female Sexual Function
Pfaus, J. G., Giuliano, F., & Gelez, H. (2007) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2007.00610.x · Cited by 114
Gruber, C. W., Muttenthaler, M., & Freissmuth, M. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210793292474 · Cited by 110
Cyclic Peptides: Promising Scaffolds for Biopharmaceuticals
Gang, D., Kim, D.-W., & Park, H.-S. (2018) · Genes · doi:10.3390/genes9110557 · Cited by 107
Echinocandins: structural diversity, biosynthesis, and development of antimycotics
Hüttel, W. (2020) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-020-11022-y · Cited by 106
Rewriting Medical History: Charles Best and the Banting and Best Myth
Bliss, M. (1993) · Journal of the History of Medicine and Allied Sciences · doi:10.1093/jhmas/48.3.253 · Cited by 105
Shailubhai, K., Comiskey, S., Foss, J. A., Feng, R., Barrow, L., Comer, G. M., & Jacob, G. S. (2013) · Digestive Diseases and Sciences · doi:10.1007/s10620-013-2684-z · Cited by 98
Cyclic Peptides as Novel Therapeutic Microbicides: Engineering of Human Defensin Mimetics
Falanga, A., Nigro, E., Biasi, M.-G. D., Daniele, A., Morelli, G., Galdiero, S., & Scudiero, O. (2017) · Molecules · doi:10.3390/molecules22071217 · Cited by 96
Oritavancin: A Long-Half-Life Lipoglycopeptide
Saravolatz, L. D., & Stein, G. E. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ311 · Cited by 93
Diversity, Ecology, and Prevalence of Antimicrobials in Nature
Mullis, M. M., Rambo, I. M., Baker, B. J., & Reese, B. K. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02518 · Cited by 91
La structure de la vasopressine de boeuf
Acher, R., & Chauvet, J. (1953) · Biochimica et Biophysica Acta · doi:10.1016/0006-3002(53)90173-5 · Cited by 91
Clinical Pharmacokinetics and Pharmacodynamics of Micafungin
Wasmann, R. E., Muilwijk, E. W., Burger, D. M., Verweij, P. E., Knibbe, C. A. J., & Brüggemann, R. J. M. (2017) · Clinical Pharmacokinetics · doi:10.1007/s40262-017-0578-5 · Cited by 87
Vancomycin and Oritavancin Have Different Modes of Action in Enterococcus faecium
Patti, G. J., Kim, S. J., Yu, T., Dietrich, E., Tanaka, K. S. E., Parr, T. R., Far, A. R., & Schaefer, J. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.06.064 · Cited by 82
Nature-Derived Peptides: A Growing Niche for GPCR Ligand Discovery
Muratspahić, E., Freissmuth, M., & Gruber, C. W. (2019) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2019.03.004 · Cited by 81
Micafungin: a sulfated echinocandin
Hashimoto, S. (2009) · The Journal of Antibiotics · doi:10.1038/ja.2008.3 · Cited by 75
Romidepsin targets multiple survival signaling pathways in malignant T cells
Valdez, B. C., Brammer, J. E., Li, Y., Murray, D. L., Liu, Y., Hosing, C. M., Nieto, Y. L., Champlin, R. E., & Andersson, B. S. (2015) · Blood Cancer Journal · doi:10.1038/bcj.2015.83 · Cited by 75
Shailubhai, K. (2015) · World Journal of Gastrointestinal Pharmacology and Therapeutics · doi:10.4292/wjgpt.v6.i4.213 · Cited by 73
Passioura, T., Liu, W., Dunkelmann, D. L., Higuchi, T., & Suga, H. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.8b03367 · Cited by 72
Woo, S., Gardner, E. R., Chen, X., Ockers, S. B., Baum, C. E., Sissung, T. M., Price, D. K., Frye, R., Piekarz, R., Bates, S. E., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1215 · Cited by 71
CyClick Chemistry for the Synthesis of Cyclic Peptides
Adebomi, V., Cohen, R. D., Wills, R. D., Chavers, H. A. H., Martin, G. E., & Raj, M. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201911900 · Cited by 71
Yang, Y., Fang, J., Guo, X., Dai, N., Shen, X., Yang, Y., Sun, J. P., Bhandari, B. R., Reasner, D. S., Cronin, J. A., et al. (2018) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14086 · Cited by 68
Ribosomal Synthesis of Backbone-Cyclic Peptides Compatible with In Vitro Display
Takatsuji, R., Shinbara, K., Katoh, T., Goto, Y., Passioura, T., Yajima, R., Komatsu, Y., & Suga, H. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.8b05327 · Cited by 67
Anaphylaxis and Hypotension after Administration of Peginesatide
Bennett, C. L., Jacob, S., Hymes, J., Usvyat, L. A., & Maddux, F. W. (2014) · New England Journal of Medicine · doi:10.1056/nejmc1400883 · Cited by 59
La structure de la vasopressine de boeuf
Acher, R., & Chauvet, J. (1954) · Biochimica et Biophysica Acta · doi:10.1016/0006-3002(54)90202-4 · Cited by 59
Liu, T., Joo, S. H., Voorhees, J. L., Brooks, C. L., & Pei, D. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.01.015 · Cited by 57
Melanocortin Receptors as Targets in the Treatment of Obesity
Heisler, L. K., Farooqi, I. S., & Lam, D. D. (2007) · Current Topics in Medicinal Chemistry · doi:10.2174/156802607780906564 · Cited by 56
Kuglstatter, A., Mueller, F., Kusznir, E. A., Gsell, B., Stihle, M., Thoma, R., Benz, J., Aspeslet, L. J., Freitag, D. G., & Hennig, M. (2011) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444910051905 · Cited by 53
Current Mechanistic and Pharmacodynamic Understanding of Melanocortin-4 Receptor Activation
Sharma, S., Garfield, A., Shah, B. P., Kleyn, P., Ichetovkin, I., Moeller, I., Mowrey, W. R., & van der Ploeg, L. (2019) · Molecules · doi:10.3390/molecules24101892 · Cited by 53
Regulation of appetite to treat obesity
Kim, G. W., Lin, J. E., Valentino, M. A., Colón‐González, F., & Waldman, S. A. (2011) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.11.3 · Cited by 52
Harrison, S. J., Bishton, M. J., Bates, S. E., Grant, S., Piekarz, R., Johnstone, R. W., Dai, Y., Lee, B., Araujo, M. E., & Prince, H. M. (2012) · Epigenomics · doi:10.2217/epi.12.52 · Cited by 52
Peginesatide for the treatment of anemia due to chronic kidney disease – an unfulfilled promise
Hermanson, T., Bennett, C. L., & Macdougall, I. C. (2016) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2016.1218467 · Cited by 51
Telavancin: a novel lipoglycopeptide for serious Gram-positive infections
Laohavaleeson, S., Kuti, J. L., & Nicolau, D. P. (2007) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.3.347 · Cited by 48
Ahsan, M. K., Tchernychev, B., Kessler, M. M., Solinga, R. M., Arthur, D., Linde, C. I., Silos‐Santiago, I., Hannig, G., & Ameen, N. A. (2017) · Physiological Reports · doi:10.14814/phy2.13299 · Cited by 48
Methodologies for Backbone Macrocyclic Peptide Synthesis Compatible With Screening Technologies
Shinbara, K., Liu, W., van Neer, R. H. P., Katoh, T., & Suga, H. (2020) · Frontiers in Chemistry · doi:10.3389/fchem.2020.00447 · Cited by 48
New, Potent, Selective, and Short-Acting Peptidic V1aReceptor Agonists
Wiśniewski, K., Galyean, R., Tariga, H., Alagarsamy, S., Croston, G. E., Heitzmann, J., Kohan, A., Wiśniewska, H., Laporte, R., Rivière, P. J.-M., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200278m · Cited by 47
Belley, A. C., Harris, R. J., Beveridge, T. J., Parr, T. R., & Moeck, G. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00603-08 · Cited by 39
Site‐Selective Peptide Macrocyclization
Wills, R. D., Adebomi, V., & Raj, M. (2020) · ChemBioChem · doi:10.1002/cbic.202000398 · Cited by 39
Mental Health of Adolescent Mothers
ZUCKERMAN, B. S., Amaro, H. D. L. A., & Beardslee, W. R. (1987) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/00004703-198704000-00008 · Cited by 37
Thomas, R. H., & Allmond, K. (2013) · Europe PMC (PubMed Central) · Cited by 36
Harnessing cyclotides to design and develop novel peptide GPCR ligands
Muratspahić, E., Koehbach, J., Gruber, C. W., & Craik, D. J. (2020) · RSC Chemical Biology · doi:10.1039/d0cb00062k · Cited by 36
Clinical Pharmacokinetics and Pharmacodynamics of Telavancin Compared with the Other Glycopeptides
al Jalali, V., & Zeitlinger, M. A. (2018) · Clinical Pharmacokinetics · doi:10.1007/s40262-017-0623-4 · Cited by 35
BOUBCHIR, K. I. , Boutemeur‐Kheddis, B., Rabia, C., et al. (2017) · Molecules · doi:10.3390/molecules23010008 · Cited by 32
Drugs in early clinical development for the treatment of female sexual dysfunction
Belkin, Z. R., Krapf, J. M., & Goldstein, A. T. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2015.978283 · Cited by 30
Ma, Y., Zhang, Y., Zhai, Y., Zhu, Z., Pan, Y., Qian, D., Su, S., Fan, X., & Duan, J. (2016) · Molecules · doi:10.3390/molecules22010007 · Cited by 30
Plecanatide: First Global Approval
Al-Salama, Z. T., & Syed, Y. Y. (2017) · Drugs · doi:10.1007/s40265-017-0718-0 · Cited by 29
Novel Somatostatin Receptor Ligands Therapies for Acromegaly
Paragliola, R. M., & Salvatori, R. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00078 · Cited by 29
Brancale, A., Shailubhai, K., Ferla, S., Ricci, A., Bassetto, M., & Jacob, G. (2017) · Pharmacology Research & Perspectives · doi:10.1002/prp2.295 · Cited by 28
Roque, M. V., & Camilleri, M. (2011) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.11.30 · Cited by 27
Shao, L., Li, J., Liu, A., Chang, Q., Lin, H., & Chen, D. (2012) · Applied and Environmental Microbiology · doi:10.1128/aem.02792-12 · Cited by 25
In Vitro Selection of Unnatural Cyclic Peptide Libraries via mRNA Display
Ma, Z., & Hartman, M. C. T. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-379-0_21 · Cited by 24
Kuhn, J., Basin, C., Mollard, M., de Rougé, B., Baudoin, C., Obach, R., & Tolis, G. (1993) · European Journal of Clinical Pharmacology · doi:10.1007/bf00315353 · Cited by 24
Construction of Peptide Macrocycles via Radical-Mediated Intramolecular C–H Alkylations
Hu, X., Chen, X., Li, B., He, G., & Chen, G. (2021) · Organic Letters · doi:10.1021/acs.orglett.0c03940 · Cited by 20
Jarmuż, A., Zielińska, M., Storr, M., & Fichna, J. (2015) · Neurogastroenterology & Motility · doi:10.1111/nmo.12574 · Cited by 18
Telavancin (vibativ), a new option for the treatment of gram-positive infections.
Plotkin, P., Patel, K., Uminski, A., & Marzella, N. (2011) · PubMed Central · Cited by 17
Green, J. M., Leu, K., Worth, A., Mortensen, R. B., Martinez, D. K., Schatz, P. J., Wojchowski, D. M., & Young, P. R. (2012) · Experimental Hematology · doi:10.1016/j.exphem.2012.02.007 · Cited by 15
Voclosporin as a Treatment for Noninfectious Uveitis
Schultz, C. L. (2013) · Ophthalmology and Eye Diseases · doi:10.4137/oed.s7995 · Cited by 15
Genetically Encoded Cyclic Peptide Libraries: From Hit to Lead and Beyond
Valentine, J., & Tavassoli, A. (2018) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2018.09.020 · Cited by 14
Anidulafungin: an evidence-based review of its use in invasive fungal infections.
Davis, S. L., & Vázquez, J. A. (2008) · PubMed Central · Cited by 12
Arthikala, M., Nanjareddy, K., & Lara, M. (2018) · Genes · doi:10.3390/genes9010011 · Cited by 11
SEPARATION OF THE ACTIVE PRINCIPLES OF THE POSTERIOR LOBE OF THE PITUITARY GLAND
(1928) · JAMA · doi:10.1001/jama.1928.02690350036015 · Cited by 6
Clarification of Linaclotide Pharmacology Presented in a Recent Clinical Study of Plecanatide
Busby, R. W., & Ortiz, S. R. (2014) · Digestive Diseases and Sciences · doi:10.1007/s10620-013-2953-x · Cited by 5
Verma, R. K., Green, J. M., Leu, K., et al. (2012) · Blood · doi:10.1182/blood.v120.21.2089.2089 · Cited by 1
Cited by
Cyclic Peptides for Drug Development
Ji, X., Nielsen, A. L., & Heinis, C. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202308251 · Cited by 411
Zhang, C., Xu, Z., Lin, K., Zhu, N., Zhang, C., Xu, W., Guo, J., Su, A., Li, C., & Duan, H. (2025) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5c00227 · Cited by 12
Lin, H., Zhu, C., Shang, T., Zhu, N., Lin, K., Zhang, C., Shao, X., Wang, X., & Duan, H. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c00896 · Cited by 10
Wu, D., & Zou, Y. (2026) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5c03236 · Cited by 3
Metadata
- Authors
- Zhang, H., & Chen, S.
- Venue
- RSC Chemical Biology
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2022
- Volume
- 3
- Issue
- 1
- Pages
- 18-31
- ISSN
- 2633-0679 (ISSN-L)
- OpenAlex
- W3212051308
- Cited by
- 319
- References
- 136
- FWCI
- 12.68
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.